Thursday’s Top Upgrades (and Downgrades): Visa Inc (V), The Home Depot, Inc. (HD)

This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines include new upgrades for Visa Inc (NYSE:V) and UnitedHealth Group Inc. (NYSE:UNH), but downgrades for both The Home Depot, Inc. (NYSE:HD) and Lowe’s Companies, Inc. (NYSE:LOW). Let’s take them in order:

Visa, American Express, MastercardPut Visa back in your wallet
Credit card company Visa missed earnings estimates last month, but with the bad news out of the way, Swiss megabanker UBS decided to remove its sell rating on the stock this morning, and upgraded to neutral. According to the analyst, Visa’s doubling down on full-year guidance, plus its modest dividend yield and promises to buy back stock are providing a “floor” to the stock’s price, limiting downside risk.

Unfortunately, the analyst is wrong.

Priced at nearly 44 times earnings today after the past year’s 33% gains, Visa’s stock is vastly overpriced even if it does manage to grow earnings at the 18% annualized rate Wall Street has it pegged for. As for the dividend, an 0.8% yield is hardly something to crow about. And topping it all off, Visa’s vaunted free cash flow has slowed to a dribble, as the company generated just $524 million in real cash profit over the past year — far lower than its $2.4 billion in claimed GAAP earnings.

In short, UBS may see the bad news as past. I think it’s only just beginning.

United Healthcare: Healthy once more?
Meanwhile, over at Oppenheimer, investment bankers are even more optimistic about the valuation at the nation’s biggest health insurance provider, UnitedHealth Group — and this time, they’ve got more of a leg to stand on.

Oppy thinks UnitedHealth is priced to “outperform” the market, and that shares will rise to $66 over the course of the next 12 months. The company’s 11% projected growth rate, 10.4 P/E ratio, and modest 1.5% dividend yield all suggest the analyst is right about that — the stock is undervalued.

Based on its “total return” ratio — predicted earnings growth plus dividend yield — of 12.5 today, a rough estimation of the stock’s true worth shows UnitedHealth to be about 17% undervalued at today’s prices. Thus, a 20% move such as the one Oppy suggests looks entirely reasonable, and the analyst’s $66 price target — right on the mark.

Home Depot and Lowe’s
It’s not all good news and happy talk today, however. While UBS and Oppenheimer were busy making their picks, analysts over at Stifel Nicolaus produced a pair of pans, downgrading both of the nation’s biggest home improvement retailers to “hold.”

Does it seem unfair to lump Home Depot and Lowe’s together in one shopping basket… and then shove that basket out into traffic? It’s not. In fact, with both stocks trading at a P/E ratio of roughly 23, both paying about a 1.6% dividend yield, both struggling under sizable debt loads, and both pegged for about 16% long-term earnings growth, it’s actually harder to tell these two stocks apart than to just lump ‘em together and declare: “I’m not impressed.”

Although it’s true that if the home improvement giants succeed in hitting their numbers, and producing growth at the expected rates, they’re not dreadfully overvalued at today’s prices; neither are they cheap. When you’re already selling $50 billion (Lowe’s) or $70 billion (Home Depot) worth of goods annually, growing that number 16% a year, for five straight years, is no easy trick.

Considering the high P/E ratios that both stocks sport, I’d say the downside risk here quite simply eclipses any gains shareholders may see from trying to capitalize on a strengthening housing market. Stifel’s right to warn investors away.

Fool contributor Rich Smith has no position in any stocks mentioned. The Motley Fool recommends Home Depot, Lowe’s, UnitedHealth Group, and Visa.

link

The article Thursday’s Top Upgrades (and Downgrades) originally appeared on Fool.com and is written by Rich Smith.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!